(Q41113513)

English

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.

scientific article published on 19 November 2015

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Pieter J Westenend

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Carolien Smorenburg

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

A C M van Bommel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C A Drukker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M van der Heiden-van der Loo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S C Linn

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E J Th Rutgers

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S G Elias

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Th van Dalen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

19 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Genetics in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

720-726

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26583684%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

An introduction to instrumental variables for epidemiologists.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Use of instrumental variable in prescription drug research with observational data: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2015.152

21 January 2018

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Nottingham prognostic index in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European inter-institutional impact study of MammaPrint

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualization of therapy using Mammaprint: from development to the MINDACT Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of 70-gene prognosis signature in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/26583684

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41113513&oldid=2204295310"